Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report.

Saved in:
Bibliographic Details
Title: Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report.
Authors: Zhong, Rui1 (AUTHOR), Li, Hui1 (AUTHOR), Liu, Yanling2 (AUTHOR), Zhang, Shuang3 (AUTHOR), Liu, Jingjing3 (AUTHOR), Huang, Zhicheng4 (AUTHOR), Cheng, Ying1,3 (AUTHOR) chengying@csco.org.cn
Source: Thoracic Cancer. Feb2020, Vol. 11 Issue 2, p456-460. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 141526891
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zhong%2C+Rui%22">Zhong, Rui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Hui%22">Li, Hui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yanling%22">Liu, Yanling</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Shuang%22">Zhang, Shuang</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Jingjing%22">Liu, Jingjing</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Zhicheng%22">Huang, Zhicheng</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cheng%2C+Ying%22">Cheng, Ying</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<i> chengying@csco.org.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Thoracic+Cancer%22">Thoracic Cancer</searchLink>. Feb2020, Vol. 11 Issue 2, p456-460. 5p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=141526891
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/1759-7714.13286
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 456
    Titles:
      – TitleFull: Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhong, Rui
      – PersonEntity:
          Name:
            NameFull: Li, Hui
      – PersonEntity:
          Name:
            NameFull: Liu, Yanling
      – PersonEntity:
          Name:
            NameFull: Zhang, Shuang
      – PersonEntity:
          Name:
            NameFull: Liu, Jingjing
      – PersonEntity:
          Name:
            NameFull: Huang, Zhicheng
      – PersonEntity:
          Name:
            NameFull: Cheng, Ying
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 17597706
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Thoracic Cancer
              Type: main
ResultId 1